Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.
暂无分享,去创建一个
Jonathan J. Lewis | L. Mariani | V. Mazzaferro | P. Srivastava | E. Regalia | M. Schiavo | T. Camerini | S. Andreola | G. Parmiani | L. Rivoltini | M. Carrabba | R. Camerini | J. Coppa | M. Corsi | A. Marchiano
[1] Stephanie Green,et al. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria , 1992, Investigational New Drugs.
[2] Jonathan J. Lewis,et al. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Francesco M Marincola,et al. Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? , 2002, Journal of the National Cancer Institute.
[4] B. Nordlinger,et al. Liver metastases from colorectal cancer: the turning point. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] S. Lipsitz,et al. Abstracts reprinted from Journal of Clinical Oncology , 2002, Annals of Surgical Oncology.
[6] D. Schadendorf,et al. Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity. , 2002, Cancer research.
[7] N. Kemeny,et al. Colorectal Cancer: A Clinical Guide to Therapy , 2001 .
[8] J. Figueras,et al. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases , 2001, The British journal of surgery.
[9] Mark M. Davis,et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Srivastava,et al. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. , 2001, Immunity.
[11] P. Srivastava,et al. Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases. , 2001, Methods in molecular biology.
[12] R. Kiessling,et al. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. , 2001, Cancer research.
[13] A. Eggermont,et al. Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial. , 2000, Journal of immunological methods.
[14] Jonathan J. Lewis,et al. Immunization of cancer patients with autologous cancer‐derived heat shock protein gp96 preparations: A pilot study , 2000, International journal of cancer.
[15] M. Lorenz,et al. Surgical resection of liver metastases of colorectal carcinoma: short and long-term results. , 2000, Seminars in oncology.
[16] E. Thiel,et al. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. , 2000, Cancer research.
[17] Sylvia Janetzki,et al. Evaluation of CD8+ T‐cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide , 2000, International journal of cancer.
[18] S. Kawasaki,et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. , 2000, Annals of surgery.
[19] A. Wells,et al. Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. , 2000, Immunology today.
[20] J. Manola,et al. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] L H Blumgart,et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. , 1999, The New England journal of medicine.
[22] L H Blumgart,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.
[23] Mihir S. Wagh,et al. The Dual Nature of Specific Immunological Activity of Tumor-derived gp96 Preparations , 1999, The Journal of experimental medicine.
[24] P. Srivastava,et al. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. , 1999, Journal of immunology.
[25] M. Hanna,et al. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial , 1999, The Lancet.
[26] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.
[27] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[28] P. Srivastava,et al. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. , 1998, Immunity.
[29] P. Srivastava,et al. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. , 1997, Science.
[30] Anne Simon Moffat,et al. Resurgent Forests Can Be Greenhouse Gas Sponges , 1997, Science.
[31] R. Issels,et al. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. , 1997, Journal of immunology.
[32] B. Nordlinger,et al. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.
[33] K. Sakaguchi,et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes , 1994, The Journal of experimental medicine.
[34] S. Rosenberg,et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] P. Srivastava,et al. Heat shock protein 70-associated peptides elicit specific cancer immunity , 1993, The Journal of experimental medicine.
[36] H. Rockette,et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. , 1988, Journal of the National Cancer Institute.
[37] E. Grundmann,et al. Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsies , 1986 .
[38] E. Appella,et al. A mouse tumor-specific transplantation antigen is a heat shock-related protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[39] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .